Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Co. Creates, Facilitates CRO Marketplace

PHARMA: Doubles Revenue to $ reported $50.27 million in 2017 revenue, a whopping increase from $23.07 million in 2016 and $6 million in 2015.

Vertex Pharmaceuticals Expands San Diego Footprint

Boston-based Vertex Pharmaceuticals has opened a 170,000-square-foot research facility in San Diego, more than doubling the company’s footprint locally.

Robotic Surgery Rides Tech Momentum Wave

MEDICINE: High Volume a Must; Adoption Becoming Norm

In San Diego hospitals, robots are on the rise, judging by splashy marketing and an increase in robotic surgery cases, per data obtained by the San Diego Business Journal.

Tease photo

Ionis Pharmaceuticals Hires New Chief Business Officer

Damien McDevitt has joined Carlsbad’s Ionis Pharmaceuticals as chief business officer.

Soccer Phenomenon Endorses SleepScore

What does SleepScore Labs have in common with Portugal and Real Madrid? They all have Cristiano Ronaldo working for them.

UC San Diego Launches Center to Spark Anti-Parasitic Drugs

A new UC San Diego center is targeting an unmet need: parasitic infections hurting poor and underserved communities.

Senomyx Shareholder Calls for Sale of Co., Chair Resignation

A shareholder of San Diego-based biotech Senomyx is pushing for the company’s chairman to resign, an immediate company sale and a new board seat.

Alzheimer’s Association Awards $175,000 Fellowship to UC San Diego Researcher

The San Diego/Imperial Chapter of the Alzheimer’s Association awarded a three-year, $175,000 fellowship to a UC San Diego researcher on a quest to determine the earliest indications of Alzheimer’s disease.

China’s CROs Make Connection in S.D.

PHARMA: They’re Part of Growing Biotech Relationship

In San Diego, the last decade gave rise to biotechs farming out work to contract research organizations, or CROs. It’s an industry increasingly colored by China.

Metacrine Raises $65 Million in Series C Round

San Diego biotech Metacrine, which is working on drugs for liver, metabolic and gastrointestinal diseases, last week closed a $65 million Series C round.

Trovagene Closes $18M Public Offering

San Diego biotech Trovagene closed an $18 million public offering on June 12.

Salk Researcher Resigns After Investigation

A well-known researcher at Salk Institute for Biological Studies resigned on June 11 after an investigation into his conduct.

Vical Pulls Plug on Herpes Vaccine Program

San Diego-based Vical is terminating its herpes vaccine candidate following not-so-great mid-stage clinical trial results.

Oska Wellness Hires New COO/CFO

A COO/CFO gig at Carlsbad’s Oska Wellness belongs to Bob Ohlweiler, who has held positions with Hewlett-Packard, Kodak, Yahoo!, Razer, and MusicMatch.

Venter Exits CEO Role

Craig Venter is retiring as the CEO of San Diego-based Human Longevity Inc., about five months after reassuming the role.